{"nctId":"NCT01290094","briefTitle":"A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-NaÃ¯ve Women With Post-Menopausal Osteoporosis","startDateStruct":{"date":"2011-04"},"conditions":["Post Menopausal Osteoporosis"],"count":41,"armGroups":[{"label":"Single Arm","type":"EXPERIMENTAL","interventionNames":["Drug: ibandronate [Bonviva/Boniva]"]}],"interventions":[{"name":"ibandronate [Bonviva/Boniva]","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female patients, \\> 50 years of age\n* Diagnosed osteoporosis\n* Bone mineral density \\< minus 2.5 SD or osteoporotic fracture\n* At least 3 years after menopause\n\nExclusion Criteria:\n\n* Impaired renal function\n* Contra-indication to Calcium or Vitamin D therapy\n* Previous or current treatment with biphosphonates","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in Mean Lumbar Spine Bone Mineral Density (BMD) at Month 12","description":"Percent change was calculated as \\[(measure at time \"t\" minus \\[-\\] measure at baseline) divided by (/) measure at baseline\\] multiplied by (\\*) 100, where t=12 months. The baseline value is used as a reference to calculate the relative change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.67","spread":"7.86"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in Mean Lumbar Spine BMD at Month 24","description":"Percent change was calculated as \\[(measure at time \"t\" - measure at baseline)/measure at baseline\\]\\*100, where t=24 months. The baseline value is used as a reference to calculate the relative change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.27","spread":"8.00"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in Mean Hip Bone BMD at Month 12","description":"Percent change was calculated as \\[(measure at time \"t\" - measure at baseline)/measure at baseline\\]\\*100, where t=12 months. The baseline value is used as a reference to calculate the relative change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.68","spread":"4.66"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in Mean Hip BMD at Month 24","description":"Percent change was calculated as \\[(measure at time \"t\" - measure at baseline)/measure at baseline\\]\\*100, where t=24 months. The baseline value is used as a reference to calculate the relative change from baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.71","spread":"5.09"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine T-score at Month 12 and 24","description":"Percent change was calculated as \\[(measure at time \"t\" - measure at baseline)/measure at baseline\\]\\*100, where t=12 and 24 months. The baseline value is used as a reference to calculate the relative change from baseline. T-score is the number of standard deviations above or below the mean for a healthy 30 year old adult of the same sex and ethnicity as the participant. A T-score with above -1 is normal bone density level. A T-score between -1 and -2.5 means that the bone density is below normal and it might be a sign of an osteopenia and may also lead into osteoporosis. A T-score below -2.5 indicates osteoporosis. A T-score below -2.5 in combination with a prevalent fracture indicates serious osteoporosis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.47","spread":"12.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.48","spread":"13.43"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Hip T-score at Month 12 and 24","description":"Percent change was calculated as \\[(measure at time \"t\" - measure at baseline)/measure at baseline\\]\\*100, where t=12 and 24 months. The baseline value is used as a reference to calculate the relative change from baseline. T-score is the number of standard deviations above or below the mean for a healthy 30 year old adult of the same sex and ethnicity as the participant. A T-score with above -1 is normal bone density level. A T-score between -1 and -2.5 means that the bone density is below normal and it might be a sign of an osteopenia and may also lead into osteoporosis. A T-score below -2.5 indicates osteoporosis. A T-score below -2.5 in combination with a prevalent fracture indicates serious osteoporosis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.31","spread":"16.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.98","spread":"17.90"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Received All Planned Study Medication (Compliance)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null}]}]}]},{"type":"SECONDARY","title":"Correlation Coefficient of Participant's Profile With Compliance","description":"Participant's profile included age, year since menopause, fracture history, and BMD at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":40},"commonTop":["Flu like symptoms","Neuralgia","Gastrointestinal pain","Injection site reaction"]}}}